Lentiviral-Mediated Interleukin-10 Gene Therapy for Lung Transplantation

We read with great interest the article published by Oishi and colleagues,1 which reported that lentiviral-mediated interleukin-10 (IL-10) gene therapy decreased allograft lung rejection. We would like to congratulate Oishi and colleagues1 for this elegant study. In addition, we admire the work that has been done by that laboratory (led by Dr Keshavjee) regarding gene delivery in lung transplantation, and personally we2 share the overall enthusiasm of Oishi and colleagues.1 We would like to add several discussion points that we believe will increase the interest in this emerging topic.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Thoracic: Lung Transplant: Letter to the Editor Source Type: research